Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by Montevialeon Oct 12, 2017 11:48pm
201 Views
Post# 26808025

RE:RE:A chance to look foolish... Q1

RE:RE:A chance to look foolish... Q1 Buckshoot, correct me if I misunderstood your thesis.   

After the market becomes saturated with cannabis, an "oversupply" situation, CGC opens their taps repalcing low cost greenhouse product with higher cost indoor product thereby driving low cost producers out of business. Instead of a race to the bottom, you have a race to the top.  Indoor producers, with higher growing costs, win in the long run because they charge more for their product.  

Forget Germany, just wait until the Chinese market opens up...1.4 billion people.  Textbooks will be written after CGC dominates the Chinese market with their higher cost product.   

In all fairness to Buckshot, for those not familiar with his thesis, you can read about it by clicking on the following link...  
https://www.stockhouse.com/companies/bullboard?symbol=t.weed&postid=26807618

M

Buckshot26 wrote: Good post Blue but I can't believe you wrote this:

"Opex should be up a bit given sales effort for Phase II with uncertain sales conversion due to lag between sales effort and results. "
Read more at https://www.stockhouse.com/companies/bullboard/t.aph/aphria-inc?postid=26792350#IbJiCjKCb8HR2GF8.99

I thought that concept was lost on you guys :)

I'm actually cheering for you Aphria tomorrow. Canopy has been doing all the heavy lifting for the past two months, time for you to start pulling your weight :)


Bullboard Posts